TY - JOUR
T1 - Web-based intervention for depressive symptoms in adults with types 1 and 2 diabetes mellitus
T2 - A health economic evaluation
AU - Nobis, Stephanie
AU - Ebert, David Daniel
AU - Lehr, Dirk
AU - Smit, Filip
AU - Buntrock, Claudia
AU - Berking, Matthias
AU - Baumeister, Harald
AU - Snoek, Frank
AU - Funk, Burkhardt
AU - Riper, Heleen
PY - 2018/4/1
Y1 - 2018/4/1
N2 - Background: Web-based interventions are effective in reducing depression. However, the evidence for the cost-effectiveness of these interventions is scarce. Aims: The aim is to assess the cost-effectiveness of a web-based intervention (GET.ON M.E.D.) for individuals with diabetes and comorbid depression compared with an active control group receiving web-based psychoeducation. Method: We conducted a cost-effectiveness analysis with treatment response as the outcome and a cost-utility analysis with qualityadjusted life-years (QALYs) alongside a randomised controlled trial with 260 participants. Results: At a willingness-to-pay ceiling of €5000 for a treatment response, the intervention has a 97% probability of being regarded as costeffective compared with the active control group. If society is willing to pay €14 000 for an additional QALY, the intervention has a 51% probability of being cost-effective. Conclusions: This web-based intervention for individuals with diabetes and comorbid depression demonstrated a high probability of being cost-effective compared with an active control group.
AB - Background: Web-based interventions are effective in reducing depression. However, the evidence for the cost-effectiveness of these interventions is scarce. Aims: The aim is to assess the cost-effectiveness of a web-based intervention (GET.ON M.E.D.) for individuals with diabetes and comorbid depression compared with an active control group receiving web-based psychoeducation. Method: We conducted a cost-effectiveness analysis with treatment response as the outcome and a cost-utility analysis with qualityadjusted life-years (QALYs) alongside a randomised controlled trial with 260 participants. Results: At a willingness-to-pay ceiling of €5000 for a treatment response, the intervention has a 97% probability of being regarded as costeffective compared with the active control group. If society is willing to pay €14 000 for an additional QALY, the intervention has a 51% probability of being cost-effective. Conclusions: This web-based intervention for individuals with diabetes and comorbid depression demonstrated a high probability of being cost-effective compared with an active control group.
UR - http://www.scopus.com/inward/record.url?scp=85044469169&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85044469169&partnerID=8YFLogxK
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85044469169&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/30071909
U2 - https://doi.org/10.1192/bjp.2018.10
DO - https://doi.org/10.1192/bjp.2018.10
M3 - Article
C2 - 30071909
SN - 0007-1250
VL - 212
SP - 199
EP - 206
JO - British Journal of Psychiatry
JF - British Journal of Psychiatry
IS - 4
ER -
